298 related articles for article (PubMed ID: 10545258)
1. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
[TBL] [Abstract][Full Text] [Related]
2. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
3. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.
Moscona A; Peluso RW
Microb Pathog; 1996 Mar; 20(3):179-84. PubMed ID: 8965678
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.
Huberman K; Peluso RW; Moscona A
Virology; 1995 Dec; 214(1):294-300. PubMed ID: 8525632
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
7. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion.
Moscona A; Peluso RW
J Virol; 1992 Nov; 66(11):6280-7. PubMed ID: 1328668
[TBL] [Abstract][Full Text] [Related]
8. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.
Prince GA; Ottolini MG; Moscona A
J Virol; 2001 Dec; 75(24):12446-51. PubMed ID: 11711635
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
[TBL] [Abstract][Full Text] [Related]
11. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
[TBL] [Abstract][Full Text] [Related]
12. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
[TBL] [Abstract][Full Text] [Related]
13. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
14. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity.
Moscona A; Peluso RW
J Virol; 1993 Nov; 67(11):6463-8. PubMed ID: 8411349
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
Palmer SG; Porotto M; Palermo LM; Cunha LF; Greengard O; Moscona A
mBio; 2012; 3(3):. PubMed ID: 22669629
[TBL] [Abstract][Full Text] [Related]
16. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.
Bousse T; Takimoto T; Gorman WL; Takahashi T; Portner A
Virology; 1994 Nov; 204(2):506-14. PubMed ID: 7941317
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
18. Human parainfluenza virus 3 neuraminidase activity contributes to dendritic cell maturation.
Horga MA; Macip S; Tuyama AC; Tan MC; Gusella GL
Viral Immunol; 2005; 18(3):523-33. PubMed ID: 16212531
[TBL] [Abstract][Full Text] [Related]
19. A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein.
Yuasa T; Kawano M; Tabata N; Nishio M; Kusagawa S; Komada H; Matsumura H; Ito Y; Tsurudome M
Virology; 1995 Feb; 206(2):1117-25. PubMed ID: 7531915
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.
Yuan P; Thompson TB; Wurzburg BA; Paterson RG; Lamb RA; Jardetzky TS
Structure; 2005 May; 13(5):803-15. PubMed ID: 15893670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
